FDG PET/CT AND PSMA PET/CT IN MUSCULOSKELETAL SOFT TISSUE SARCOMAS

FDG PET/CT AND PSMA PET/CT IN MUSCULOSKELETAL SOFT TISSUE SARCOMAS

Introduction/Justification: Soft tissue musculoskeletal sarcoma (STS) is a rare and varied class of mesenchymal-derived malignancies. Due to its histopathological heterogeneity and presence in different body locations, its diagnosis and treatment continue to present a significant medical challenge....

Full description

Saved in:

Bibliographic Details
Main Authors:	Ellen Nogueira Lima, Thaisa Ramos Freire, Mayara Branco E. Silva, Natalia Tobar Toledo Prudente Silva, Thiago Alves, Allan Santos, Mariana Lima, José Carvalheira, Mauricio Etchebehere, Elba Etchebehere
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Hematology, Transfusion and Cell Therapy
Subjects:	18 F-PSMA PET/CT 18F-FDG PET/CT Sarcoma Theranostics
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137925000392
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COMPARISON BETWEEN 18F-PSMA AND 18F-FDG RADIOTRACERS FOR PET/CT IN THE EVALUATION OF PATIENTS WITH METASTATIC MELANOMA
by: Thiago Soare Rocha Alves, et al.
Published: (2025-05-01)

EVALUATION OF 18F-PSMA PET/CT UPTAKE IN PATIENTS WITH GASTRIC ADENOCARCINOMA: AN EXPLORATORY ANALYSIS
by: Renata Erbert Contriciani, et al.
Published: (2025-05-01)

DUAL-TRACER PET/CT IMAGING IN HEPATOCELLULAR CARCINOMA: COMPARING THE PERFORMANCE OF 18F-FDG AND 18F-PSMA
by: Giulia Picciola Bordoni, et al.
Published: (2025-05-01)

Diagnostic value of dual-tracer PET/CT with [18F]FDG and PSMA ligands in prostate cancer: an updated systematic review
by: Cesare Michele Iacovitti, et al.
Published: (2025-07-01)

Comparing the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in breast cancer recurrence: a systematic review and meta-analysis
by: Shiqing Liu, et al.
Published: (2025-08-01)

PAPEL DO PET/CT COM 18F- FDG NA AVALIAÇÃO DO COLANGIOCARCINOMA: UM ESTUDO RETROSPECTIVO
by: Marcelo Moreira da Silva, et al.
Published: (2025-05-01)

Head-to-head comparison of 68Ga-PSMA-11 and 18F-FDG in delayed PET/CT imaging in prostate cancer diagnosis
by: Biyao Hu, et al.
Published: (2025-04-01)

CT-SEGMENTED BONE SUV IN MULTIPLE MYELOMA: A COMPARATIVE STUDY OF ¹⁸F-FDG AND ⁶⁸GA-PSMA PET/CT
by: Alexandre Mercuri Barbosa, et al.
Published: (2025-05-01)

THE DIAGNOSTIC ROLE OF 18F-FDG-PET/CT IN PATIENTS WITH CONSTITUTIONAL SYMPTOMS
by: Mustafa Altınkaynak, et al.
Published: (2023-03-01)

ACHADOS METABÓLICOS PÓS VACINAÇÃO PARA COVID-19 EM PET-CT COM 18F-FDG
by: Antonio Eduardo Santos Stroppa
Published: (2025-05-01)

PET/CT con hallazgo incidental de captación de 18F-PSMA en paciente con COVID-19
by: Jhonatan Gómez-Domínguez, et al.
Published: (2025-01-01)

The clinical benefits of [18F]AlF-NOTA-octreotide PET/CT in staging and restaging patients with gastroenteropancreatic neuroendocrine neoplasms: comparison of [18F]FDG PET/CT
by: Donghe Chen, et al.
Published: (2025-07-01)

An Uncommon Presentation of Leptomeningeal Metastases in Breast Carcinoma Detected by F-18 FDG PET/CT
by: Gavini Surya, et al.
Published: (2022-09-01)

18F-FDG PET/CT Imaging of Boari Flap Mimicking Urothelial Cancer Recurrence
by: Sharon E. Fishberg, et al.
Published: (2022-06-01)

[18F]FDG PET/CT versus [18F]FDG PET/MRI in staging of non-small cell lung cancer: a head-to-head comparative meta-analysis
by: Dandan Yu, et al.
Published: (2025-01-01)

Theranostics Nuclear Medicine in Prostate Cancer
by: Helena Lima, et al.
Published: (2024-11-01)

A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer
by: Matthew J. Roberts, et al.
Published: (2025-07-01)

18F-FDG PET/CT-assisted diagnosis of mediastinal poorly differentiated neuroendocrine lung cancer presenting with bone metastasis as the initial symptom
by: Lingyu Hou, et al.
Published: (2025-05-01)

Distribution of metastases after radiotherapy in relation to radiation exposure fields: evaluation by 18F-FDG PET/CT
by: Jiucen Liang, et al.
Published: (2024-11-01)

Asymptomatic Distant Subcutaneous Metastases Detected by 18 F-FDG-PET/CT in a Patient with Breast Carcinoma
by: Kuruva Manohar, et al.
Published: (2012-01-01)

Furosemide Reduces Radionuclide Activity in the Bladder in <sup>18</sup>F-PSMA-1007-PET/CT: A Single-Center Retrospective Intra-Individual Comparative Study
by: Martin A. Cahenzli, et al.
Published: (2025-07-01)

Primary Mediastinal B-Cell Lymphoma and [18F]FDG PET/CT: What We Learned and What Is New
by: Anna Giulia Nappi, et al.
Published: (2025-04-01)

Retroperitoneal fibrosis masquerading as para-aortic lymphadenopathy on F-18 FDG PET/CT in a patient with carcinoma cervix
by: R. Kashyap, et al.
Published: (2011-01-01)

The baseline 18F-FDG PET/CT imaging features in pediatric patients with congenital neuroblastoma
by: Keyu Zhang, et al.
Published: (2025-08-01)

[18F]-FDG PET-CT in Malignant Melanoma
by: Teodora Sidonia Mititelu, et al.
Published: (2025-05-01)

[18F]-Fluoroestradiol PET/CT: a modern look at nuclear medicine applications
by: A. V. Parnas, et al.
Published: (2021-06-01)

Comparative Diagnostic Value of 18F-FDG–PET–CT and Intraoperative Examination in Cervical Cancer Staging
by: Goran Malenković, et al.
Published: (2024-10-01)

<sup>18</sup>F-FDG PET/CT in the Diagnosis of Cervical Cancer
by: A. V. Leontyev, et al.
Published: (2022-12-01)

DETECTION OF EXTRANODAL INVOLVEMENT IN PATIENTS WITH LYMPHOMAS USING THE COMBINED PET-CT
by: А. V. Vazhenin, et al.
Published: (2016-02-01)

Diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in preoperative staging of locoregional urinary bladder cancer: a systematic review and Meta-Analysis
by: Ahmed Saad Abdlkadir, et al.
Published: (2025-07-01)

The role of 18F-FDG PET/CT in diagnosing cardiac infiltration and therapeutic evaluation in extranodal nasal-type NK/T-cell lymphoma: a case report
by: Taiping Liao, et al.
Published: (2025-03-01)

The clinical application value and the imaging characteristic of 18F-FDG PET/CT in tuberculous pericarditis
by: Xiaoqing Du, et al.
Published: (2025-05-01)

Comparing the Diagnostic Performance of [18F]PSMA‐1007 With [68Ga]Ga‐PSMA‐11 in PET/CT Imaging and Staging of Recurrent Prostate Cancer
by: Negar Abdi, et al.
Published: (2025-03-01)

18F-FDG PET/CT in the diagnosis and treatment of atypical extensive skin lesions in extranodal natural killer/T-cell lymphoma, nasal type: a case report
by: Xu-Sheng Liu, et al.
Published: (2025-04-01)

SSB expression is associated with metabolic parameters of 18F-FDG PET/CT in lung adenocarcinoma and can improve diagnostic efficiency
by: Zi-Yue Liu, et al.
Published: (2024-11-01)

Effect of statins on arterial wall inflammation as assessed by 18F-FDG PET CT: an updated systematic review and meta-analysis
by: Tannaz Jamialahmadi, et al.
Published: (2024-12-01)

Definitions of Incidental [<sup>18</sup>F]FDG PET/CT Findings in the Literature: A Systematic Review and Definition Proposal
by: Jacob Pilegaard Mølstrøm, et al.
Published: (2024-12-01)

Assessment of the particular demand for 18FDG/PET-CT procedures: a discussion regarding new incorporations by the SUS
by: Adriana de Souza Medeiros Batista, et al.
Published: (2022-12-01)

<sup>18</sup>F-FDG PET/CT Findings in Glandular Tularemia
by: Freja Gustafsson, et al.
Published: (2025-05-01)

18 F-FDG Positron Emission Tomography in Multifocal Pyomyositis
by: C. N. B. Harisankar, et al.
Published: (2012-01-01)